Riskpilot← Back to searchSign inGet full accessDeltoideum AB
ABActiveOrg 5568033780Alvägen 22General medical practice activities · NACE 8621Est. 20101 employees
Revenue 2025
SEK 1,2M
-18% vs 2024
EBITDA margin
82.4%
-21% vs 2024
Equity ratio
50.2%
Financial strength
Net profit 2025
SEK 661K
-12% vs 2024
| Revenue | SEK 1,2M | -18% |
| EBITDA | SEK 995K | -21% |
| Net profit | SEK 661K | -12% |
| Total assets | SEK 2,5M | +23% |
| Equity | SEK 1,3M | +39% |
| Employees | 1 | — |
Legal name
Deltoideum AB
Org number
5568033780
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 april 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarverksamhet och därmed förenlig verksamhet.
Address
Alvägen 22
Phone
+4687585150
Email
petersvozil900@msn.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 552 | 356 | 1 038 | 1 474 | 1 208 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 376 | 214 | 748 | 1 267 | 995 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 376 | 214 | 748 | 1 267 | 995 |
| Net financials | −1 | — | 1 | 15 | 23 |
| Profit before tax | 374 | 258 | 619 | 956 | 839 |
| Tax | −81 | −56 | −132 | −201 | −178 |
| Net profit | 293 | 202 | 487 | 755 | 661 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 766 | 559 | 1 175 | 2 071 | 2 540 |
| Equity | 405 | 307 | 564 | 919 | 1 276 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 127 | 62 | 291 | 506 | 440 |
| Total debt | 127 | 62 | 291 | 506 | 440 |
EBITDA margin
82.4%
This company
15.8%
Market median
+422% vs market
20212025
Equity ratio
50.2%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
51.8%
This company
18.4%
Market median
+182% vs market
20212025
Net profit margin
54.7%
This company
8.1%
Market median
+575% vs market
20212025
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Deltoideum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Wilhelm A Björlin Svozil | Deputy Board Member | 0 companies |
| Peter Ladislav Svozil | Board of Directors | 0 companies |